Completed NA INTERVENTIONAL 2-arm NCT01287507

Lactoferrin Prophylaxis in VLBW and Regulator T-cells

Oral Lactoferrin Prophylaxis to Prevent Sepsis and Necrotising Enterocolitis of Very Low Birth Weight Neonates in Neonatal Intensive Care Unit and Effect on T-regulatory Cells.

Sponsor: Ankara University

Conditions Late Onset Neonatal Sepsis Necrotising Enterocolitis Very Low Birth Weight Infants

Interventions Lactoferrin (bovine origin)

Updated 6 times since 2017 Last updated: Aug 25, 2014 Started: Dec 31, 2009 Primary completion: Jan 31, 2011 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Late Onset Neonatal Sepsis and Necrotising Enterocolitis and is currently completed. Ankara University leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ankara University

Data source: Ankara University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ankara, Turkey (Türkiye)